CNRGH

Mathilde André et al.
Positive selection in the genomes of two Papua New Guinean populations at distinct altitude levels
Nature Communications 2024, vol. 15, issue 1
doi: 10.1038/s41467-024-47735-1

Manon Baudic et al.
TAD boundary deletion causes PITX2-related cardiac electrical and structural defects
Nature Communications 2024, vol. 15, issue 1
doi: 10.1038/s41467-024-47739-x

Rayan Bensenane et al.
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia–Telangiectasia Mutated Variant Carriers
Cancers 2024, vol. 16, issue 7
doi: 10.3390/cancers16071417

Yann Loe-Mie et al.
De Novo Variants Found in Three Distinct Schizophrenia Populations Hit a Common Core Gene Network Related to Microtubule and Actin Cytoskeleton Gene Ontology Classes
Life 2024, vol. 14, issue 2
doi: 10.3390/life14020244

Aurore Pire et al.
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival
European Journal of Cancer 2024, vol. 200
doi: 10.1016/j.ejca.2024.113583

Alexandre How-Kit et al.
The CEPH aging cohort and biobank: a valuable collection of biological samples from exceptionally long-lived French individuals and their offspring for longevity studies
GeroScience 2023, vol. 46, issue 2
doi: 10.1007/s11357-023-01037-4

Laura vanden Brande et al.
Pathogenic DPAGT1 variants in limb‐girdle congenital myasthenic syndrome (LG‐CMS) associated with tubular aggregates and ORAI1 hypoglycosylation
Neuropathology and Applied Neurobiology 2023, vol. 50, issue 1
doi: 10.1111/nan.12952

Jill Pilet et al.
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Nature Communications 2023, vol. 14, issue 1
doi: 10.1038/s41467-023-42418-9

Thomas Husson et al.
Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders
European Journal of Human Genetics 2023
doi: 10.1038/s41431-023-01474-x

M

Alex Clavería-Cabello et al.
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology 2023, vol. 79, issue 4
doi: 10.1016/j.jhep.2023.05.031